LambdaVision Secures NASA Phase 2 InSPA Award to Advance Manufacturing Efforts in Low-Earth Orbit

WOODBRIDGE, Conn.--(BUSINESS WIRE)--LambdaVision, an innovative biotech company developing a protein-based artificial retina to help patients regain sight lost to retinal degenerative diseases, has been awarded a National Aeronautics and Space Administration (NASA) Phase 2 In Space Production Applications (InSPA) award. This NASA award will enable LambdaVision to further develop layer-by-layer manufacturing processes to support artificial retina production, while improving quality, scale, and G